- BioTelemetry (BEAT -0.6%) Q4 results: Revenues: $43.7M (+32.0%); COGS: $19.1M (+55.3%); R&D Expense: $1.7M (-10.5%); SG&A: $19.1M (+23.2%); Operating Loss: ($0.7M) (-450.0%); Net Loss: ($1.7M) (-999%); Loss Per Share: ($0.06); CF Ops: $4.2M (+0.5%).
-
FY2014 results: Revenues: $166.6M (+28.6%); COGS: $73.1M (+45.0%); R&D Expense: $7.4M (+1.4%); SG&A: $73.9M (+17.7%); Operating Loss: ($4.3M) (+37.7%); Net Loss: ($9.8M) (-34.2%); Loss Per Share: ($0.37) (-27.6%); Quick Assets: $20M (-9.9%); CF Ops: $8.8M (-22.1%).
- No guidance given.